Lake Bleu Capital
Hong Kong, Hong Konglakebleu-cap.com
Overview
Lake Bleu Capital is a Hong Kong-based investment platform that specializes in healthcare in Asia/Greater China . With a long-term investment horizon, it manages strategies through both public and private equity investments, focusing primarily on mid-to-late-stage investments . The firm specializes in investing in the healthcare, pharmaceutical, and technology innovation sectors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| METiS Therapeutics | May 2026 | IPO | Co-investor |
| METiS Pharmaceuticals | May 2026 | IPO | Co-investor |
| Sanegene Bio | Dec 2025 | Series B | Co-investor |
| Expedition Therapeutics | Oct 2025 | Series A | Co-investor |
| MolBreeding Biotech | Jul 2024 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
